Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ANGO · against 1,216 other Healthcare companies
Ranked #834 of 1,217 · scores higher than 31% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 30–39, including ANGO · Click a bar to see the companies
Mainly because of its earnings per share growth and 3-year revenue growth, which are weaker than most Healthcare peers.
| Metric | ANGO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 8.2% | 6.1% | 57% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -1.1% | 5.8% | 27% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 834 | 2.2B CNY (≈$310M) | 31 | 39 | |
| 834 | 63.5B JPY (≈$432M) | 31 | 57 | |
| 834 | 193.1B JPY (≈$1.3B) | 31 | 48 | |
| 834 | 21.6B CNY (≈$3.0B) | 31 | 70 | |
| 834 | 493M USD | 31 | 38 | |
| 834 | 70.9B ZAR (≈$3.9B) | 31 | 48 | |
| 834 | 302M USD | 31 | 17 | |
| 834 | 1.4B SEK (≈$143M) | 31 | 47 | |
| 834 | 10.8B USD | 31 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score